共 66 条
[1]
Ernster VL(2002)Detection of ductal carcinoma in situ in women undergoing screening mammography J Natl Cancer Inst 94 1546-54
[2]
Ballard-Barbash R(2005)The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up Cancer 103 2481-4
[3]
Barlow WE(2002)Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 1233-41
[4]
Sanders ME(2006)Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381-7
[5]
Schuyler PA(2001)Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience Semin Oncol 28 400-18
[6]
Dupont WD(2001)Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden Cancer Epidemiol Biomarkers Prev 10 495-9
[7]
Fisher B(1994)Ductal carcinoma in situ: a proposal for a new classification Semin Diagn Pathol 11 167-80
[8]
Anderson S(2002)Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS Br J Cancer 87 615-20
[9]
Bryant J(2003)Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 95-102
[10]
Bijker N(2001)Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 19 2263-71